Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash Flows from Operating Activities:
Net loss	$ (514,447)	$ (766,491)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation and amortization	17,169	19,404
Net realized (gains) on the sale of securities	(208,502)	(10,764)
Amortization of investment securities, net	16,468	7,397
Deferred acquisition costs capitalized	(144,069)	(127,119)
Deferred acquisition costs amortized	84,225	89,099
Interest credited on deposit type contracts	63,607	32,531
(Increase) decrease in operating assets:
Investment income due and accrued	(6,101)	(4,177)
Reinsurance related assets	(226)	(116,698)
Other assets	(249,929)	57,526
Increase (decrease) in operating liabilities:
Policyowner benefit reserves	797,659	1,039,565
Advance premiums	66,399	25,848
Other liabilities	(2,320)	(3,097)
Accounts payable and accrued expenses	73,984	(45,891)
Net cash (used in) provided by operating activities	(6,083)	197,133
Cash Flows from Investing Activities:
Purchase of fixed income investments	(2,100,968)	(1,512,774)
Purchase of equity investments	(3,124,648)	(805,227)
Proceeds from fixed income sales and repayments	1,532,509	467,504
Proceeds from equity sales and repayments	1,299,640	92,247
Purchase of property, equipment and software	(6,000)
Net cash (used in) investing activities	(2,399,467)	(1,758,250)
Cash Flows from Financing Activities:
Receipts on deposit-type contracts	1,000,563	949,295
Withdrawals on deposit-type contracts	(271,319)	(153,699)
Proceeds received from exercise of warrants, net of costs of issuance	259,418	1,834,677
Net cash provided by financing activities	988,662	2,630,273
Net (decrease) increase in cash and cash equivalents	(1,416,888)	1,069,156
Cash and Cash Equivalents:
Beginning	3,145,745	2,466,526
Ending	$ 1,728,857	$ 3,535,682